17 research outputs found
Comptage direct des echantillons Plasmatiques en Scintillation Liquide par Etalonnage Interne-Externe
Orientações para pacing cardíaco e terapia de ressincronização cardíaca [Guidelines for cardiac pacing and cardiac resynchronization therapy]
Cartilage Degeneration, Subchondral Mineral and Meniscal Mineral Densities in Hartley and Strain 13 Guinea Pigs
Eletrencefalograma antes e após hemodiálise, diálise peritoneal e transplante renal: estudo de correlações da atividade de fundo com a bioquímica plasmática
Estudamos as correlações entre atividade de fundo no EEG e anormalidades bioquímicas do plasma em 49 pacientes com insuficiência renal crônica. Foi realizado estudo do EEG e bioquímico antes e após hemodiálise em 20 pacientes, antes e após diálise peritoneal em 14 e antes e após transplante renal em 15 pacientes. Observamos piora do EEG após hemodiálise e diálise peritoneal e melhora do EEG após transplante, sugerindo que em nossos pacientes as alterações da atividade de fundo induzidas pela uremia crônica eram reversíveis. Com base em nossos resultados, consideramos difícil estabelecer correlações entre o EEG e alterações da bioquímica plasmática. Entretanto, há correlação estatística entre hipernatremia, melhora da acidose metabólica, aumento da relação zinco/cobre e piora da atividade de fundo no EEG
2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
For several years the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) decided not to produce their own guidelines on the diagnosis and treatment of hypertension but to endorse the guidelines on hypertension issued by the World Health Organization (WHO) and International Society of Hypertension (ISH) with some adaptation to reflect the situation in Europe. However, in 2003 the decision was taken to publish ESH/ ESC specific guidelines based on the fact that, because the WHO/ISH Guidelines address countries widely varying in the extent of their health care and availability of economic resource, they contain diagnostic and therapeutic recommendations that may be not totally appropriate for European countries. In Europe care provisions may often allow a more in-depth diagnostic assessment of cardiovascular risk and organ damage of hypertensive individuals as well as a wider choice of antihypertensive treatment. In 2007 the ESC/ESH decide to release new guidelines in consideration of considerable additional evidence on important issues related to diagnostic and treatment approaches to hypertension has become available
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).
Contains fulltext :
52036.pdf ( ) (Open Access
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
Contains fulltext :
52037.pdf (publisher's version ) (Closed access